The introduction of nicotinamide to be a nicotine alternative in e-cigarette and smokeless solutions represents a big regulatory challenge for your FDA. Nicotinamide does not have nicotinic receptor agonist action and is known to work as a sedative at superior dosages6. The promises produced by Nicotine River, ECBlend, and also other suppliers that